Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System

Recruiting

Phase 3

AcyclovirPhase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System

Sponsor:

National Center for Research Resources (NCRR)

Code:

NCT00006132

Conditions

Herpes Simplex

Eligibility Criteria

Sex: All

Age: 0 - 28

Healthy Volunteers: Not accepted

Interventions

acyclovir

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by National Center for Research Resources (NCRR) on 2005-06-24.